Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Received: 16 March 2020
Accepted: 27 October 2020
First Online: 7 November 2020
Ethics approval and consent to participate
: This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable.
: Herbert H Loong has received research funding from Novartis Pharmaceuticals Corporation for clinical trials and for physicians’ educational activities, but no funding was received for this study. Carlos KH Wong and Linda KS Leung have no potential conflicts of interest to declare. Zheng-Yi Zhou and Jipan Xie are employees of Analysis Group, Inc., which has received consultancy fees from Novartis Pharmaceuticals Corporation for this study. Catherine PK Chan, Andrea Chang, and Meaghan Gibbs are employees of Novartis Pharmaceuticals Corporation and may own stock or stock options.